CNE0000014W7
CNE0000014W7
JIANGSU HENGRUI PHARMACEUTICALS
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 31.629.416.194 | 27.984.605.342 | 13.0% |
| Cost of Revenue | 4.362.655.815 | 3.848.177.392 | 13.4% |
| Gross Profit | 27.266.760.378 | 24.136.427.950 | 13.0% |
| 18.670.348.627 | 17.333.295.381 | 7.7% | |
| Operating Income | 8.596.411.752 | 6.803.132.569 | 26.4% |
| Pretax Income | 8.707.625.538 | 7.169.689.996 | 21.5% |
| Net Income Common Stockholders | 7.711.054.812 | 6.336.527.015 | 21.7% |
| -- | -- | -- | |
| -- | -- | -- |